INCREASED BODY-TEMPERATURE, CORTISOL SECRETION, AND HYPOTHALAMIC EXPRESSION OF C-FOS, CORTICOTROPIN-RELEASING HORMONE AND INTERLEUKIN-1-BETA MESSENGER-RNAS, FOLLOWING CENTRAL ADMINISTRATION OF INTERLEUKIN-1-BETA IN THE SHEEP
Sv. Vellucci et al., INCREASED BODY-TEMPERATURE, CORTISOL SECRETION, AND HYPOTHALAMIC EXPRESSION OF C-FOS, CORTICOTROPIN-RELEASING HORMONE AND INTERLEUKIN-1-BETA MESSENGER-RNAS, FOLLOWING CENTRAL ADMINISTRATION OF INTERLEUKIN-1-BETA IN THE SHEEP, Molecular brain research, 29(1), 1995, pp. 64-70
There is evidence to indicate that cytokines of the interleukin series
act within the brain to influence physiological responses to patholog
ical states or stressful events. This investigation examined the effec
ts of intracerebroventricular (lateral ventricle) injection of human r
ecombinant interleukin-1 beta (IL-1 beta) on body temperature, hormone
(catecholamine, cortisol, prolactin, growth hormone) release and hypo
thalamic expression of c-fos, corticotrophin-releasing hormone (CRH),
vasopressin (AVP) and IL-1 beta mRNAs in the sheep. A preliminary stud
y showed that central administration of 10 mu g IL-1 beta significantl
y (P < 0.05) increased body temperature (by 1.2 degrees C) over a 140
min period but did not affect catecholamine secretion. A second experi
ment using graded doses (100 ng, 1 mu g, 10 mu g) of IL-1 beta indicat
ed that only the highest dose significantly (P < 0.01) increased corti
sol concentrations and that none of the treatments altered the secreti
on of prolactin or growth hormone. In a third study, changes in gene e
xpression in the hypothalamus were examined using in situ hybridizatio
n histochemistry following treatment with 10 mu g IL-1 beta. The resul
ts showed that IL-1 beta increased c-fos mRNA in the paraventricular (
PVN, P < 0.05) and supraoptic (SON, P < 0.05) nuclei, CRH mRNA in the
PVN (P < 0.01) and IL-1 beta mRNA in the PVN (P < 0.05). There was, ho
wever, no change in AVP mRNA in either the PVN or the SON.